{"id":5450,"date":"2022-05-03T11:57:11","date_gmt":"2022-05-03T15:57:11","guid":{"rendered":"https:\/\/bridge-bio.local\/?page_id=5450"},"modified":"2024-09-11T10:45:24","modified_gmt":"2024-09-11T14:45:24","slug":"business-development","status":"publish","type":"page","link":"https:\/\/bridgebio.com\/licensing-opportunities","title":{"rendered":"licensing opportunities"},"content":{"rendered":"<p>Strategic partnerships are an integral part of our model. We value collaboration with companies and institutions at the forefront of scientific innovation and we are focused on building robust relationships and alliances in the service of helping patients in need.<\/p>\n<p>We seek academic and industry partners, both within the United States and globally, committed to making life-changing medicines as rapidly and safely as possible. Additionally, we are open to discussing portfolio divestments and licensing of pharmaceutical assets.<\/p>\n<p>BridgeBio is seeking partners for the following programs:<\/p>\n<ul>\n<li><strong>BBP-589 \u2013 Recombinant collagen 7 for\u00a0dystrophic epidermolysis bullosa (rDEB)<\/strong>\n<ul>\n<li>Completed Phase 2 clinical trial designed to evaluate<strong>\u00a0<\/strong>safety and tolerability of BBP-589, as well as clinical proof-of-concept, and initiated a Phase 2 extension study<\/li>\n<\/ul>\n<\/li>\n<li><strong>BBP-681 \u2013 Topical PI3KA inhibitor for venous and lymphatic malformations (VM and LM)<\/strong>\n<ul>\n<li>Phase 1\/2 clinical trial underway<\/li>\n<\/ul>\n<\/li>\n<li><strong>BBP-711 \u2013 GO inhibitor for primary hyperoxaluria type 1 (PH1) and recurrent kidney stone formers<\/strong>\n<ul>\n<li>Phase 1 clinical trial completed<\/li>\n<\/ul>\n<\/li>\n<li><strong>BBP-398 \u2013 SHP2 inhibitor for MAPK\/RAS driven cancers<\/strong><\/li>\n<li><strong>BBP-561 \u2013 KLK 5\/7 inhibitor for Netherton syndrome<\/strong>\n<ul>\n<li>Investigational New Drug (IND)\u00a0enabling studies underway<\/li>\n<\/ul>\n<\/li>\n<li><strong>BBP-631 \u2013 Adeno-associated virus (AAV) 5 gene therapy for congenital adrenal hyperplasia (CAH)<\/strong>\n<ul>\n<li>Phase 1\/2 clinical trial underway<\/li>\n<\/ul>\n<\/li>\n<li><strong>BBP-818 \u2013 AAV gene therapy for classic galactosemia<\/strong>\n<ul>\n<li>IND-enabling studies underway<\/li>\n<\/ul>\n<\/li>\n<li><strong>BBP-815 \u2013 AAV\u00a0gene therapy for nonsyndromic hearing loss\u00a0<\/strong>\n<ul>\n<li>Preclinical development<\/li>\n<\/ul>\n<\/li>\n<li><strong>BBP-472 \u2013 PI3KB inhibitor for PTEN autism<\/strong>\n<ul>\n<li>Preclinical development<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>Contact <a href=\"mailto:licensing@bridgebiodev.wpengine.com\"><strong>licensing@bridgebiodev.wpengine.com<\/strong><\/a> for more information<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Strategic partnerships are an integral part of our model. We value collaboration with companies and institutions at the forefront of scientific innovation and we are focused on building robust relationships and alliances in the service of helping patients in need. We seek academic and industry partners, both within the United States and globally, committed to [&hellip;]<\/p>\n","protected":false},"author":26,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/page-legal.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-5450","page","type-page","status-publish","hentry"],"acf":{"hero_background_color":"red","hero_image":false,"hero_video":false,"hero_title":"","hero_cta_type":"","hero_cta_text":"","hero_cta_internal_link":false,"hero_cta_external_link":"","hero_cta_video":false,"page_intro_text":"","page_content_primary":"","page_content_secondary":"","page_content_tertiary":"","cta_external_link_new_tab":false},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Strategic Partnerships | Business Development | BridgeBio<\/title>\n<meta name=\"description\" content=\"Strategic partnerships are an integral part of our model. We seek academic and industry partners committed to making life-changing medicines. Learn more!\" \/>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Strategic Partnerships | Business Development | BridgeBio\" \/>\n<meta property=\"og:description\" content=\"Strategic partnerships are an integral part of our model. We seek academic and industry partners committed to making life-changing medicines. Learn more!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bridgebio.com\/licensing-opportunities\/\" \/>\n<meta property=\"og:site_name\" content=\"BridgeBio\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-11T14:45:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bridgebio.com\/licensing-opportunities\/\",\"url\":\"https:\/\/bridgebio.com\/licensing-opportunities\/\",\"name\":\"Strategic Partnerships | Business Development | BridgeBio\",\"isPartOf\":{\"@id\":\"https:\/\/bridgebio.com\/#website\"},\"datePublished\":\"2022-05-03T15:57:11+00:00\",\"dateModified\":\"2024-09-11T14:45:24+00:00\",\"description\":\"Strategic partnerships are an integral part of our model. We seek academic and industry partners committed to making life-changing medicines. Learn more!\",\"breadcrumb\":{\"@id\":\"https:\/\/bridgebio.com\/licensing-opportunities\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bridgebio.com\/licensing-opportunities\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bridgebio.com\/licensing-opportunities\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bridgebio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"licensing opportunities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bridgebio.com\/#website\",\"url\":\"https:\/\/bridgebio.com\/\",\"name\":\"BridgeBio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bridgebio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Strategic Partnerships | Business Development | BridgeBio","description":"Strategic partnerships are an integral part of our model. We seek academic and industry partners committed to making life-changing medicines. Learn more!","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Strategic Partnerships | Business Development | BridgeBio","og_description":"Strategic partnerships are an integral part of our model. We seek academic and industry partners committed to making life-changing medicines. Learn more!","og_url":"https:\/\/bridgebio.com\/licensing-opportunities\/","og_site_name":"BridgeBio","article_modified_time":"2024-09-11T14:45:24+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@BridgeBioPharma","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bridgebio.com\/licensing-opportunities\/","url":"https:\/\/bridgebio.com\/licensing-opportunities\/","name":"Strategic Partnerships | Business Development | BridgeBio","isPartOf":{"@id":"https:\/\/bridgebio.com\/#website"},"datePublished":"2022-05-03T15:57:11+00:00","dateModified":"2024-09-11T14:45:24+00:00","description":"Strategic partnerships are an integral part of our model. We seek academic and industry partners committed to making life-changing medicines. Learn more!","breadcrumb":{"@id":"https:\/\/bridgebio.com\/licensing-opportunities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bridgebio.com\/licensing-opportunities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bridgebio.com\/licensing-opportunities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bridgebio.com\/"},{"@type":"ListItem","position":2,"name":"licensing opportunities"}]},{"@type":"WebSite","@id":"https:\/\/bridgebio.com\/#website","url":"https:\/\/bridgebio.com\/","name":"BridgeBio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bridgebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/pages\/5450"}],"collection":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/comments?post=5450"}],"version-history":[{"count":0,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/pages\/5450\/revisions"}],"wp:attachment":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/media?parent=5450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}